Hofmeyr G J
Department of Obstetrics and Gynaecology, Coronation Hospital and University of the Witwatersrand, 7 York Road, Parktown 2193, Johannesburg, South Africa.
Cochrane Database Syst Rev. 2000(2):CD000004. doi: 10.1002/14651858.CD000004.
Abdominal decompression was developed as a means of pain relief during labour. It has also been used for complications of pregnancy, and in healthy pregnant women in an attempt to improve fetal wellbeing and intellectual development.
The objective of this review was to assess the effects of antenatal abdominal decompression for maternal hypertension or impaired fetal growth, on perinatal outcome.
The Cochrane Pregnancy and Childbirth Group trials register and the Cochrane Controlled Trials Register were searched. Date of last search: February 1998.
Randomised or quasi-randomised trials comparing abdominal decompression with no decompression in women with pre-eclampsia and/or fetuses thought to be compromised.
Eligibility and trial quality were assessed by one reviewer.
Three studies were included, all with the possibility of containing serious bias. Therapeutic abdominal decompression was associated with the following reductions: persistent pre-eclampsia (relative risk 0.36, 95% confidence interval 0.18 to 0.72); fetal distress in labour (relative risk 0.37, 95% confidence interval 0.19 to 0.71); low birthweight (relative risk 0.50, 95% confidence interval 0.40 to 0. 63); Apgar scores less than six at one minute (relative risk 0.26, 95% confidence interval 0.12 to 0.56); and perinatal mortality (relative risk 0.39, 95% confidence interval 0.22 to 0.71).
REVIEWER'S CONCLUSIONS: Due to the methodological limitations of the studies, the effects of therapeutic abdominal decompression are not clear. The apparent improvements in birthweight and perinatal mortality warrant further evaluation of abdominal decompression where there is impaired fetal growth and possibly for women with pre-eclampsia.
腹部减压作为分娩时缓解疼痛的一种方法而被采用。它也被用于治疗妊娠并发症,以及用于健康孕妇,以试图改善胎儿健康和智力发育。
本综述的目的是评估产前腹部减压对患有妊娠高血压或胎儿生长受限的孕妇围产期结局的影响。
检索了Cochrane妊娠与分娩组试验注册库和Cochrane对照试验注册库。最后检索日期:1998年2月。
比较腹部减压与未减压对患有先兆子痫和/或被认为有问题的胎儿的妇女进行随机或半随机试验。
由一名评价员评估纳入标准和试验质量。
纳入了三项研究,所有研究都有可能存在严重偏倚。治疗性腹部减压与以下情况的减少相关:持续性先兆子痫(相对危险度0.36,95%可信区间0.18至0.72);产时胎儿窘迫(相对危险度0.37,95%可信区间0.19至0.71);低出生体重(相对危险度0.50,95%可信区间0.40至0.63);1分钟时阿氏评分低于6分(相对危险度0.26,95%可信区间0.12至0.56);以及围产期死亡率(相对危险度0.39,95%可信区间0.22至0.71)。
由于这些研究的方法学局限性,治疗性腹部减压的效果尚不清楚。出生体重和围产期死亡率的明显改善值得在胎儿生长受限的情况下以及可能对患有先兆子痫的妇女进一步评估腹部减压。